Middle East & Africa Large Molecule Bioanalytical Testing Services Market Size & Outlook
Middle East & Africa large molecule bioanalytical testing services market, 2018-2030 (US$M)
Related Markets
MEA large molecule bioanalytical testing services market highlights
- The MEA large molecule bioanalytical testing services market generated a revenue of USD 75.7 million in 2021.
- The market is expected to grow at a CAGR of 8.3% from 2022 to 2030.
- In terms of segment, clinical was the largest revenue generating phase in 2021.
- Preclinical is the most lucrative phase segment registering the fastest growth during the forecast period.
- Country-wise, South Africa is expected to register the highest CAGR from 2022 to 2030.
MEA data book summary
| Market revenue in 2021 | USD 75.7 million |
| Market revenue in 2030 | USD 155.3 million |
| Growth rate | 8.3% (CAGR from 2021 to 2030) |
| Largest segment | Clinical |
| Fastest growing segment | Preclinical |
| Historical data covered | 2018 - 2020 |
| Base year for estimation | 2021 |
| Forecast period covered | 2022 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Preclinical, Clinical |
| Key market players worldwide | Labcorp Holdings Inc, IQVIA Holdings Inc, Syneos Health, SGS AG, Toxikon, Intertek Group PLC, Pace Analytical Services, Icon PLC, Charles River Laboratories International Inc, Thermo Fisher Scientific Inc |
Other key industry trends
- In terms of revenue, MEA region accounted for 4.7% of the global large molecule bioanalytical testing services market in 2021.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 509.0 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Large Molecule Bioanalytical Testing Services Market Scope
Large Molecule Bioanalytical Testing Services Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Middle East & Africa large molecule bioanalytical testing services market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to large molecule bioanalytical testing services market will help companies and investors design strategic landscapes.
Clinical was the largest segment with a revenue share of 67.11% in 2021. Horizon Databook has segmented the Middle East & Africa large molecule bioanalytical testing services market based on preclinical, clinical covering the revenue growth of each sub-segment from 2018 to 2030.
The region has countries with relatively young population and limited budgets for pharmaceutical & biopharmaceutical R&D. Number of clinical trials in the region are also modest. These factors will result in moderate market growth of the region over the forecast period.
However, government initiatives to improve healthcare in the region are expected to drive market growth of large molecule bioanalytical testing market over the forecast years.
Reasons to subscribe to Middle East & Africa large molecule bioanalytical testing services market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Middle East & Africa large molecule bioanalytical testing services market databook
-
Our clientele includes a mix of large molecule bioanalytical testing services market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Middle East & Africa large molecule bioanalytical testing services market , including forecasts for subscribers. This continent databook contains high-level insights into Middle East & Africa large molecule bioanalytical testing services market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
MEA large molecule bioanalytical testing services market size, by country, 2018-2030 (US$M)
Middle East & Africa Large Molecule Bioanalytical Testing Services Market Outlook Share, 2021 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
